These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6610369)
1. [Hemorrhagic complications of anticoagulants (heparin and dicoumarins) in the treatment of deep venous thrombosis. Report of 176 consecutive patients]. Lozano F; Ramos M; Morán M; Almazán A; Ingelmo A; Gómez Alonso A Angiologia; 1984; 36(3):118-20. PubMed ID: 6610369 [No Abstract] [Full Text] [Related]
2. [Bleeding complications in peroral anticoagulant therapy. A retrospective study of the importance of drug synergism]. Alexanderson B; Taube A; Westerholm B Lakartidningen; 1971 Mar; 68():Suppl I:35+. PubMed ID: 5314654 [No Abstract] [Full Text] [Related]
3. [Gastrointestinal hemorrhages under anticoagulant treatment]. Labayle JM; Bodin F; Lichtenstein H; Conte M Sem Hop; 1974 Mar; 50(14):941-5. PubMed ID: 4372685 [No Abstract] [Full Text] [Related]
4. [Anticoagulant treatment and digestive hemorrhages]. Himbert J; Sée E; Thiroloix P; Lenègre J Ann Med Interne (Paris); 1971 Nov; 122(11):1055-64. PubMed ID: 5317109 [No Abstract] [Full Text] [Related]
12. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis. Stricker H; Marchetti O; Haeberli A; Mombelli G Thromb Haemost; 1999 Oct; 82(4):1227-31. PubMed ID: 10544903 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis. Hirsh J Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406 [No Abstract] [Full Text] [Related]
14. Heparin treatment of deep vein thrombosis. Effects and complications after continuous or intermittent heparin administration. Fagher B; Lundh B Acta Med Scand; 1981; 210(5):357-61. PubMed ID: 7039244 [TBL] [Abstract][Full Text] [Related]
15. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes]. MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309 [No Abstract] [Full Text] [Related]
16. Case study: complications associated with anticoagulant therapy. Davis GL; Mutnick AH Am J Med Technol; 1981 Mar; 47(3):179-82. PubMed ID: 7223763 [TBL] [Abstract][Full Text] [Related]
17. [Ambulatory treatment without complications. A 1-year experience in distal deep-vein thrombosis]. Svensson P; Lethagen S; Lindén E; Berntorp E Lakartidningen; 1994 Aug; 91(34):2950-2. PubMed ID: 7990537 [No Abstract] [Full Text] [Related]
18. [Analysis of general and hemorrhagic complications after treatment of acute proximal deep venous thrombosis of the legs treated with anticoagulants, streptokinase and thrombectomy]. Meissner AJ; Misiak A; Huszcza S; Ziemski JM Pol Merkur Lekarski; 2000 Nov; 9(53):767-71. PubMed ID: 11204326 [TBL] [Abstract][Full Text] [Related]
19. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis. Penner J N Engl J Med; 1996 Aug; 335(9):671; author reply 671-2. PubMed ID: 8692247 [No Abstract] [Full Text] [Related]
20. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]